Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

Clinical trial NCT06439225 · RECRUITING

Trial details

NCT number: NCT06439225
Sponsor: Canadian Cancer Trials Group
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Metastatic Prostate Cancer

Start date: 2024-12-30
Primary completion: 2029-09-30
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.